Fosaprepitant for Injection 150 mg per vial, Sterile lyophilized powder for Intravenous use only after reconstitution and dilution, Single Dose Vial, Rx Only, Distributed by BE Pharmaceuticals Inc. 203 New Edition Court Cary, NC 27511, Made in India, NDC 71839-104-01.
Published January 31, 2024 · Recall initiated: January 10, 2024
Summary
FDA records drug Class II recall D-0262-2024, published January 31, 2024 and initiated January 10, 2024. Recalling firm: BE PHARMACEUTICALS AG; Status: Terminated; Reported quantity: 22,176 Vials; Lot: lot #13D012AA, Exp: 08/31/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Sterility Assurance: Aseptic process simulation failure.
What to do
Voluntary: Firm initiated · Letter
Get an email if FOSAPREPITANT has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- FOSAPREPITANT
- Manufacturer
- BE PHARMACEUTICALS AG
- Distributor
- Nationwide in the USA
- UPC
- 0371839104017
- Lot
- lot #13D012AA, Exp: 08/31/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- Switzerland
Related recalls
- FDABleomycin for Injection, USP, 15 units per vial, 1 single dose glass fliptop vial, Rx Only, Distributed by:January 31, 2024
- FDACinacalcet Tablets 60mg, Rx Only, 30 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc.,January 31, 2024
- FDAMethoxsalen Capsules, USP 10mg, 50-count bottle, Rx Only, Manufactured by: Strides Pharma Science Ltd.January 31, 2024
- FDAFebuxostat Tablets 40mg, Rx Only, 30 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc.,January 31, 2024
- FDAFluocinolone Acetonide Oil, 0.01% (Ear Drops), package in 1 Oz. (20 mL fill volume) bottle, Rx only,January 31, 2024
- FDAFosaprepitant for Injection, 150 mg / vial in a 10 mL Single-Dose vial, Rx only, Fresenius Kabi, Lake Zurich,July 22, 2020
Questions about this recall
Was Fosaprepitant for Injection 150 mg per vial, Sterile lyophilized powder for Intravenous use only after reconstitution and dilution, Single Dose Vial, Rx Only, Distributed by BE Pharmaceuticals Inc. 203 New Edition Court Cary, NC 27511, Made in India, NDC 71839-104-01. recalled?
Yes. FDA published recall D-0262-2024 on January 31, 2024. Reported hazard: Lack of Sterility Assurance: Aseptic process simulation failure.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: FOSAPREPITANT. UPC: 0371839104017.